102
Participants
Start Date
September 30, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
ADX-914
Subcutaneous administration of ADX-914
Placebo
Subcutaneous administration of Placebo
Visage Clinical Research, Largo
Advanced Medical Research, PC, Sandy Springs
Medical Research Center of Miami, Miami
Well Pharma Medical Research Corporation, Miami
RM Medical Research Inc., Homestead
Apex Clinical Research Center, Painesville
GCP Research, St. Petersburg
Cahaba Dermatology Skin Health Center, Birmingham
Southern Indiana Clinical Trials, New Albany
Revival Research Corporation- Clinedge, Troy
Sneeze wheeze and Itch Associates LLC, Normal
North Texas Center for Clinical Research, Frisco
Progressive Clinical Research, San Antonio
Treasure Valley Medical Research, Boise
JBR Clinical Research, Salt Lake City
California Allergy and Asthma Medical Group- Los Angeles, Los Angeles
Dermatology Institute and Skin Care Center, Santa Monica
Torrance Clinical Research Institute Inc., Torrance
Integrated Research of Inland, Inc., Upland
First OC Dermatology, Fountain Valley
Integrative Skin Science and Research, Sacramento
Dermatology of Seattle & Bellevue, Seattle
Dermatology Specialists of Spokane, Spokane
Clinical Partners, LLC, Johnston
Q32 Bio Inc.
INDUSTRY